Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Long ME, Koirala S, Sloan S, Brown-Burke F, Weigel C, Villagomez L, et al. Resistance to PRMT5-targeted therapy in mantle cell lymphoma. Blood Adv. 2024;8(1):150-163.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

L Medeiros J, Chadburn A, Natkunam Y, Naresh KN. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. Mod Pathol. 2024;37(4):100441.

Bendari A, Hammoud H, Kumar SK, Harshan M. Commentary on Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients. J Surg Oncol. 2024;129(8):1566-1567.

Fein JA, Patel SS. Under AI's lens: spotting mutations visually. Blood Adv. 2024;8(3):827-828.

Manning JC, Boza JM, Cesarman E, Erickson D. Rapid, equipment-free extraction of DNA from skin biopsies for point-of-care diagnostics. Sci Rep. 2024;14(1):13782.

Geyer JT. Current Challenges in the Characterization of Myeloid Neoplasms. Pathobiology. 2024;91(1):5-7.

Rosenberg SM, Zheng Y, Ruddy K, Poorvu PD, Snow C, Kirkner GJ, et al. Helping ourselves, helping others: the Young Women's Breast Cancer Study (YWS) - a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and younger. BMJ Open. 2024;14(6):e081157.

Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am J Hematol. 2024;99(2):327-328.

Solomon JP. Practical Considerations for Oncogenic Fusion Detection and Reporting in Solid Tumors. J Appl Lab Med. 2024;9(1):116-123.